24/7 Patient Assistance: 760-405-8205

Hospitals & Clinics

  • Bio & Insurance Information

    Dr. Richard Garcia-Kennedy is a pathologist based in San Francisco, California. He has been practicing medicine for more than two decades. He graduated from the Medical College of Pennsylvania and continued with a residency stage in anatomic and clinical pathology at the Pacific Presbyterian Medical Center. Dr. Garcia-Kennedy is a board-certified specialist in anatomic & clinical pathology and cytopathology. He contributed to numerous publications that focused on topics like colorectal spreading tumors, liver failure caused by herpes simplex, inoperable bulky melanoma, immunodeficiency virus-associated blepharoptosis, hepatitis B, liver transplantation, benign liver tumors, lymphoproliferative disorder. At the moment, Dr. Garcia-Kennedy is associated with the California Pacific Medical Center and the Novato Community Hospital.

  • Education & Training


    Medical College of Pennsylvania

    Medical School


    Pacific Presbyterian Medical Center


  • Board Certifications

    American Board of Pathology

    American Board of Pathology - Anatomic Pathology & Clinical Pathology

  • Hospital & Practice

    California Pacific Medical Center

    Languages: English/Spanish

    (415) 600-6000

    Castro St & Duboce Ave

    San Francisco, California 94114

    Read More
  • Publications & Memberships

    Dr. Richard Garcia-Kennedy has contributed to 3 publications.

    Attempted underwater en bloc resection for large (2-4 cm) colorectal laterally spreading tumors (with video).

    Binmoeller, K. F.,Hamerski, C. M.,Shah, J. N.,Bhat, Y. M.,Kane, S. D.,Garcia-Kennedy, R.; Gastrointest. Endosc.. 2015 Feb 25.

    See more >>

    Acute liver failure caused by herpes simplex virus in a pregnant patient: Is there a potential role for therapeutic plasma exchange?

    Holt, E. W.,Guy, J.,Gordon, S. M.,Hofmann, J. C.,Garcia-Kennedy, R.,Steady, S. L.,Bzowej, N. H.,Frederick, R. T.; J Clin Apher. 2013 Jul 16.

    See more >>

    Inoperable bulky melanoma responds to neoadjuvant therapy with vemurafenib.

    Fadaki, N., Cardona-Huerta, S., Martineau, L., Thummala, S., Cheng, S. T., Bunker, S. R., Garcia-Kennedy, R., Wang, W., Minor, D., Kashani-Sabet, M., Leong, S. P.; BMJ Case Rep. 2012.

    See more >>